Press release
Bipolar Disorder Therapeutics Market To Reach A Value Of US$ 6.8 Bn By 2031
The bipolar disorder therapeutics market is projected to rise at a CAGR of 3.1% from 2022 to 2026, as per this new analysis by Fact.MR, a market research and competitive intelligence provider. Currently, the market for bipolar disorder therapeutic drugs accounts for a valuation of US$ 5.9 Bn.Download FREE Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7280
Increasing incidence of bipolar disorders and rising focus on mental health are prime factors that will govern the bipolar disorder therapeutics market potential over the forecast period of 2022-2026. Increasing initiatives from governments across the world to bolster awareness regarding mental health will majorly drive bipolar disorder therapeutics market growth across regions.
Poor lifestyle habits, high-stress environments, rising prevalence of insomnia, and advancements in therapeutics are some other factors that will influence market expansion over the forecast period.
The world has witnessed an increase in focus on mental health over the past few years and this has been majorly driven by increasing stress levels among the population across the globe.
Bipolar disorder drug manufacturers are focusing on the development of novel drugs for treatment, and are pushing for faster approvals by regulatory authorities to ensure higher market penetration and a competitive edge.
• In April 2022, BioXcel Therapeutics, a leading biopharmaceutical company known for its utilization of artificial intelligence in the development of medicine and therapeutics, announced the approval of IGALMI™ (dexmedetomidine) Sublingual Film by the Food and Drug Administration (FDA). This will be used for the treatment of bipolar I and II disorders along with the treatment of schizophrenia.
To learn more about Bipolar Disorder Drugs and Treatment Market, you can get in touch with our Analyst at
https://www.factmr.com/connectus/sample?flag=AE&rep_id=7280
Key Takeaways from Market Study
• The global bipolar disorder therapeutics market stands at a value of US$ 5.9 Bn in 2022.
• From 2022 to 2026, the market for bipolar disorder therapeutic drugs is predicted to expand at a CAGR of 3.1%.
• Projected valuation of the bipolar disorder therapeutics market for 2026 is US$ 6.8 Bn.
• Increasing awareness about mental health, rising demand for bipolar disorder drugs, and growing stress levels of the population are major factors driving market growth.
• Bipolar disorder therapeutics market growth is expected to be hampered by the side effects associated with the use of bipolar disorder drugs.
• The United States bipolar disorder therapeutics market accounts for 44.3% of the global market share in 2022.
• The market for bipolar disorder therapeutics in Germany is predicted to rise at a slow CAGR of 2.6% over the forecast period.
"Rising public awareness regarding mental health with supportive government initiatives are expected to boost bipolar disorder therapeutics market potential," says a Fact.MR analyst
Get Full Access of Complete Report: https://www.factmr.com/checkout/7280
Winning Strategy
Bipolar disorder therapeutic drug providers are focusing on various strategies to maximize their market presence across the world. These companies are also investing in the research and development of novel drugs and devices to gain a competitive edge over other market players.
Increasing awareness through government initiatives is expected to favor bipolar disorder therapeutic drug manufacturers as they capitalize on this increased awareness and drive their sales funnel. Mania and depression due to mental disorders is a common phenomenon and is often signified by mood swings and sudden mood changes.
Key Segments Covered in Bipolar Disorder Therapeutics Industry Research
• Bipolar Disorder Therapeutics Market by Type:
o Antipsychotics Drugs
o Anticonvulsants
o Mood Stabilizers
o Antidepressant Drugs
o Anti-anxiety Drugs
• Bipolar Disorder Therapeutics Market by Region:
o North America Bipolar Disorder Therapeutics Market
o Latin America Bipolar Disorder Therapeutics Market
o Europe Bipolar Disorder Therapeutics Market
o East Asia Bipolar Disorder Therapeutics Market
o South Asia & Oceania Bipolar Disorder Therapeutics Market
o Mea Bipolar Disorder Therapeutics Market
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bipolar Disorder Therapeutics Market To Reach A Value Of US$ 6.8 Bn By 2031 here
News-ID: 2851179 • Views: …
More Releases from Fact.MR

Liquid Biopsy Market to Hit USD 24.70 Billion by 2033 | Key Players Covered: Bio …
The global liquid biopsy market size is estimated at US$ 4.72 billion in 2023 and is forecasted to expand rapidly at a CAGR of 18% to reach a valuation of US$ 24.70 billion by 2033, according to a newly released market study of liquid biopsy by Fact.MR, a market research and competitive intelligence provider. This growth is driven by the increasing demand for non-invasive cancer diagnostics, advancements in next-generation sequencing…

Artificial Kidney Market is Growing at a CAGR of 13% by 2033 | Key Players: Kawa …
Artificial Kidney Market is valued at USD 1.5 billion in 2023 and is projected to surge ahead at a CAGR of 13% to reach a market size of USD 5.3 billion by the end of 2033. This robust growth is driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), affecting millions worldwide, and the limitations of current dialysis treatments. Artificial kidneys, including wearable and…

Artificial Intelligence (AI) in Retail Market is Projected to Reach USD 138.3 Bi …
The global artificial intelligence (AI) in retail market is forecast to reach USD 138.3 billion by 2035, up from USD 9.8 billion in 2025. During the forecast period, the industry is projected to register at a CAGR of 30.3%. AI-driven personalization enhances customer engagement through tailored recommendations and experiences. AI-powered demand forecasting optimizes inventory management and reduces operational inefficiencies. This rapid expansion is fueled by the increasing adoption of AI…

Mining Automation Market is Expected to Reach USD 8.4 Billion by 2035 | Fact.MR …
The global mining automation market is forecast to reach USD 8.4 billion by 2035, up from USD 4.5 billion in 2025. During the forecast period, the industry is projected to register at a CAGR of 6.4%. This growth is driven by the increasing demand for minerals, the need for sustainable and low-emission operations, labor shortages, and enhanced safety in hazardous environments. Technological advancements in AI, IoT, robotics, and digital twins…
More Releases for Bipolar
Bipolar Disorder Therapeutics Market Report 2024 - Bipolar Disorder Market Oppor …
"The Business Research Company recently released a comprehensive report on the Global Bipolar Disorder Therapeutics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Bipolar Disorder Therapeutics Market: Balancing the Mind - Unveiling Breakthroug …
Allied Market Research recently said Bipolar disorder, a mental health condition characterized by extreme shifts in mood and energy levels, affects millions of people worldwide. The quest for effective therapeutics to manage this complex disorder has seen remarkable progress in recent years. This article explores the innovative developments in bipolar disorder therapeutics, shedding light on the path to achieving a harmonious balance for those living with this condition.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞…
Insulated Gate Bipolar Transistor (IGBT) Market
New York, Global Insulated Gate Bipolar Transistor (IGBT) Market report from Global Insight Services is the single authoritative source of intelligence on Insulated Gate Bipolar Transistor (IGBT) Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation…
Bipolar Discrete Semiconductor Market
New York - “Global Bipolar Discrete Semiconductor Market” the new research report adds in Data Bridge Market Research’s reports database. This Research Report spread across 329 Page, 53 No of Tables, And 244 No of Figures with summarizing Top companies, COVID-19 impacts and supports with tables and figures.
The Bipolar Discrete Semiconductor report acts as a thorough synopsis on the study, analysis and estimation of the market and how it is…
Bipolar Disorder Epidemiology Insights to 2025
Publisher " Bipolar Disorder Manic Depression - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Bipolar Disorder Manic Depression in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Bipolar Disorder Manic Depression prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with…
Autobiographical Memoir, Bipolar Me, Relates Life Dealing With Bipolar, Depressi …
Sid Nachman has been called "one of the funniest and endearing story-tellers of his generation." That is certainly the case. But the issues he deals with in his books - bipolar disorder, depression, dyslexia and stuttering - are not subjects we might find amusing. Sid applies his acerbic wit to all of these in a writing style that is wildly entertaining and revealing. Both of his books, 'Bipolar Me'…